Right ventricular adaptation and failure in pulmonary arterial hypertension.
about
Role of Biomarkers in the Diagnosis, Risk Assessment, and Management of Pulmonary HypertensionThe emerging role of epigenetics in pulmonary arterial hypertension: an important avenue for clinical trials (2015 Grover Conference Series)World Health Organization Group I Pulmonary Hypertension: Epidemiology and Pathophysiology.Metabolic Changes Precede the Development of Pulmonary Hypertension in the Monocrotaline Exposed Rat Lung.Altered mTOR and Beclin-1 mediated autophagic activation during right ventricular remodeling in monocrotaline-induced pulmonary hypertension.Different Predictors of Right and Left Ventricular Metabolism in Healthy Middle-Aged MenChanges in Caspase-3, B Cell Leukemia/Lymphoma-2, Interleukin-6, Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor Gene Expression after Human Umbilical Cord Blood Derived Mesenchymal Stem Cells Transfusion in Pulmonary Hypertension RatEffect of early administration of lower dose versus high dose of fresh mitochondria on reducing monocrotaline-induced pulmonary artery hypertension in rat.Molecular switches under TGFβ signalling during progression from cardiac hypertrophy to heart failure.Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.NADPH oxidase: its potential role in promotion of pulmonary arterial hypertension.Right Heart End-Systolic Remodeling Index Strongly Predicts Outcomes in Pulmonary Arterial Hypertension: Comparison With Validated Models.The effects of pulmonary vasodilating agents on right ventricular parameters in severe group 3 pulmonary hypertension: a pilot study.Role of cardiac inflammation in right ventricular failure.Trimedazidine alleviates pulmonary artery banding-induced acute right heart dysfunction and activates PRAS40 in rats.Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.Stage‑dependent changes of β2‑adrenergic receptor signaling in right ventricular remodeling in monocrotaline‑induced pulmonary arterial hypertension.Assessment of right ventricular longitudinal strain by 2D speckle tracking imaging compared with RV function and hemodynamics in pulmonary hypertension.Capsaicin pretreatment reversed pulmonary arterial hypertension by alleviating inflammation via p38MAPK pathway.Right ventricular relative wall thickness as a predictor of outcomes and of right ventricular reverse remodeling for patients with pulmonary hypertension.Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy?Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.Circulatory Insufficiency and Hypotension Related to the Ductus Arteriosus in Neonates.Native T1 and T2 mapping by cardiovascular magnetic resonance imaging in pressure overloaded left and right heart diseases.Metabolic Reprogramming in the Heart and Lung in a Murine Model of Pulmonary Arterial Hypertension
P2860
Q26744186-0E68D7A6-C713-4710-AD90-892686E23264Q28069443-1D73D93A-3BFF-45EB-9D10-DCB20ADEDE4FQ30248878-E17FAC61-FDB6-4B54-BFA9-2930B7F2D830Q35944064-BFB76D0F-43FB-49E7-B6FB-86267E866D92Q36322517-93375122-1B0E-48A3-8C71-D0156F55BB67Q36387380-38C4BEDD-1541-4DF1-9CBC-4BFA8A8C1404Q36485026-DA8E8661-10F4-4547-9F68-8FBF2B7E9718Q37553700-7D69A8FA-6B2D-47CC-80B7-F5CA0926ADF8Q38597820-2C31E16B-B2FD-44CD-B1B8-DE2F324ADE16Q38692684-64E863CC-200F-44AA-A8F0-52B281C6BE6EQ39132107-C51BD101-4B7B-4600-9D26-5AC4A792C3A0Q40168224-8334E338-0708-4424-A623-E1B82C959B7DQ41859742-27866277-207E-4839-8C9C-C984F29BA171Q45068688-7899E12C-1466-4398-B15C-9427A2C92849Q46294693-617AC28C-5D09-4656-8362-507C8676423CQ47155453-AAE92F7C-A17B-4F0A-AFDA-73604B88E2B5Q47824028-28BE52D4-B931-42D0-A603-68F25C09B975Q48553117-93D6F216-1390-433F-A2E9-A00991011A40Q51102739-E8BB3CE4-AAA1-4FED-8DF9-ED6D7DA1BD46Q51749910-4A53F4D7-79E0-45CA-80C5-A5099A8D522BQ52685704-27180020-2F47-43E5-A2B1-9993CA5FA14EQ53728725-D05B578A-7C30-4C1C-9F51-D955D9E03FA2Q55054371-F4C56515-7497-4BC9-9667-AC5903F37AA6Q55649427-8CE2E74E-13BD-4E04-B7B9-3C598E2BCF88Q58777371-7CF4504B-04FF-4067-A39E-85F4F255CA92
P2860
Right ventricular adaptation and failure in pulmonary arterial hypertension.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Right ventricular adaptation and failure in pulmonary arterial hypertension
@nl
Right ventricular adaptation and failure in pulmonary arterial hypertension.
@ast
Right ventricular adaptation and failure in pulmonary arterial hypertension.
@en
type
label
Right ventricular adaptation and failure in pulmonary arterial hypertension
@nl
Right ventricular adaptation and failure in pulmonary arterial hypertension.
@ast
Right ventricular adaptation and failure in pulmonary arterial hypertension.
@en
prefLabel
Right ventricular adaptation and failure in pulmonary arterial hypertension
@nl
Right ventricular adaptation and failure in pulmonary arterial hypertension.
@ast
Right ventricular adaptation and failure in pulmonary arterial hypertension.
@en
P2093
P2860
P3181
P1476
Right ventricular adaptation and failure in pulmonary arterial hypertension.
@en
P2093
Amer M Johri
Jessica Huston
John J Ryan
Julia E Herr
Lindsay Bowman
Nathan D Hatton
Shelby Kutty
Stephen L Archer
P2860
P304
P3181
P356
10.1016/J.CJCA.2015.01.023
P407
P50
P577
2015-01-29T00:00:00Z